Clinical Trial

A Study of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD)

Terminated Phase 2
View on ClinicalTrials.gov →
Why the trial stopped
Adjustment of sponsor's product development strategy.
Summary
The GS3-007a Growth Hormone Stimulation Test (GHST) will be compared with the Insulin Tolerance Test (ITT) in an open-label, randomized, three-way crossover trial. The trial will include subjects suspected to have adult growth hormone deficiency (AGHD) and a group of healthy control subjects.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-20.
Status change: Not Yet Recruiting → Terminated 2026-05-19
Trial Details
NCT Number NCT07259564
Lead Sponsor Changchun GeneScience Pharmaceutical Co., Ltd.
Conditions Adult Growth Hormone Deficiency (AGHD)
Enrollment 120 participants
Start Date 2025-12-19
Primary Completion 2026-04-15 (estimated)
Study Completion 2026-05-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-22